Influenzavirus C Vaccine
The antigenic drift capability of influenza viruses has forced vaccine producers to update their original influenza vaccines annually to accommodate the antigenic structure of new influenza viruses. This cumbersome and laborious process is very plaguing scientists. Creative Biolabs' leadership in the vaccine industry comes from years of successful experience and is recognized by customers around the world. We have a wide range of products and services in the field of vaccines to ensure the smooth running of your research.
Influenza C Virus
Influenzavirus C belongs to the Orthomyxoviridae, viruses in the genus infect humans and pigs. Compared with influenza A and B viruses, influenza caused by influenza C virus is relatively rare, but the flu it causes is severe and it often causes local epidemics. Among the four influenza viruses in the Orthomyxoviridae, influenza caused by type A is the most serious, type B is not as serious as type A but can cause influenza outbreaks, while type C usually causes only weak symptoms. Another difference is that unlike the influenza A and B viruses, the RNA of the influenza C virus has 7 segments encoding 9 proteins, while the first 2 viruses have 8 segments in RNAs and encode at least 10 proteins.
Influenza C virus has no animal reservoirs and is less known about the virus because it is not easily separated, but there is evidence that the virus is distributed worldwide. The number of the lineages of the virus that have been determined so far is 6. Like other viruses in the Orthomyxoviridae, the influenza C virus is an enveloped RNA virus. The matrix proteins (M1) and nucleoproteins (NP) of the virus are the basis for determining the virus type. It is the M1 protein that plays a role in viral assembly, and the NP protein is responsible for transcription and replication. As mentioned earlier, influenza A and B viruses contain hemagglutinin (HA) and neuraminidase (NA) glycoproteins on the surface, while C and D contain only one hemagglutinin-esterase fusion (HEF) protein. The protein mediates the fusion of the virus with the cell membrane and promotes entry of the virus into the cell to initiate infection. Types C and D are the only influenza viruses capable of expressing esterases, which act similarly to neuraminidase of influenza A and B viruses, and function to destroy host cell receptor.
Creative Biolabs is a young but mature vaccine development company, and our expertise in the vaccine field has been recognized by customers around the world. As a disease that threatens human health from time to time, flu vaccine has always been the focus of our attention. Years of research have allowed us to successfully develop high-quality flu vaccine products and service libraries so that we can provide the most comprehensive help for your flu vaccine research.
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
